期刊文献+

人胎盘源间充质干细胞对脐血CD8^+T细胞活化及周期和IL-17分泌的影响 被引量:6

The effect of human placenta-derived mesenchymal stem cells on cord blood CD8^+T cells activation,cellcycle and secretion of IL-17
下载PDF
导出
摘要 目的:探讨人胎盘源间充质干细胞(hPMSCs)对脐血CD8+T细胞活化、周期及IL-17分泌的调节作用,为其在临床细胞治疗中的应用提供理论依据。方法:应用消化法分离、培养hPMSCs,体外扩增培养3代后用于实验;应用免疫磁珠法分选脐血CD8+T细胞;应用流式细胞术(FCM)分析hPMSCs对植物血凝素(PHA)刺激下脐血CD8+T细胞早期表型CD25、CD69表达和细胞周期的影响;佛波酯(PMA)刺激下脐血CD8+T细胞对IL-17分泌的影响。结果:hPMSCs体外可使脐血CD8+T细胞滞留于细胞周期的G0/G1期,下调活化脐血CD8+T细胞早期表型CD25、CD69的表达,上调其IL-17的分泌。结论:hPMSCs体外可通过对脐血CD8+T细胞周期的影响抑制其活化,并且上调脐血CD8+T细胞IL-17的分泌。 AIM: To study the effect of human placenta- derived mesenchymal stem cells (hPMSCs) on cord blood CD8^+ T cell activation, cell cycle and secretion of IL-17, and to provide the theoretical basis for it application in the cell- based therapies. METHODS: hPMSCs were isolated from mature placenta by the method of digestion. Then hPMSCs were cultured, expanded in vitro, and were used in test after the third passage. CD8 ^+T cells were sorted from cord blood with immunomagetic beads. FCM was used to analyze the expression of early activation phenotype, cell cycle of cord blood CD8^+ T cells and cytokine secretion. RESULTS: CD8^+T cells stimulated by PHA in the presence of hPMSCs were arrested at G0/G1 phase. The expression of the early activation marker CD25 and CD69 of cord blood CD8^+T cells was inhibited in the presence of hPMSCs. While, IL-17secretion of cord blood CD8^+T cells stimulated by PMA was increased. CONCLUSION: hPMSCs can suppress the activation of cord blood CD8^+T cells by altering T cell cycle; up-regulate the level of IL-17 secreted by cord blood CD8^+ T cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第1期17-20,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 山东省医药卫生发展计划(2007HZ039) 山东省科技发展计划(2011GGH21818) 滨州医学院科研启动基金(BY2007KYD09)
关键词 hPMSCs CD8+T细胞 免疫调节 细胞周期 IL-17 hPMSCs CD8^+ T cell immunoregulation cell cycle IL-17
  • 相关文献

参考文献5

二级参考文献47

  • 1张毅,李长东,江小霞,李荷莲,唐佩弦,毛宁.Comparison of mesenchymal stem cells from human placenta and bone marrow[J].Chinese Medical Journal,2004(6):882-887. 被引量:13
  • 2翟琼莉,邱录贵,李茜,周余,于珍,孟恒星,韩俊领,应红光,韩忠朝.体外扩增对脐血CD34^+细胞粘附特性和趋化功能的影响[J].中华医学杂志,2003,83(14):1262-1265. 被引量:4
  • 3李长东 ,张为远 ,李荷莲 ,江小霞 ,张毅 ,毛宁 .人胎盘间充质干细胞对脐血淋巴细胞转化的影响[J].中华医学杂志,2005,85(24):1704-1707. 被引量:6
  • 4栾希英,张光波,胡玉敏,於葛华,王明元,段巧艳,段祥,张学光.人骨髓MSC对PHA活化T细胞周期以及表型和细胞因子分泌的影响[J].细胞与分子免疫学杂志,2007,23(5):402-405. 被引量:16
  • 5Pittenger M F, Mackay A M, Beck S C et al. Muhilineage potential of aduh human mesenchymal stem ceils [J]. Science, 1999; 284 (5411) :143-147.
  • 6Jiang Y H,Jahagirdar B, Reinhardt R Let al. Pluripoteney of mesenchymal stem cells derived from adult marrow[ J ]. Nature, 2002 ;418:41-49.
  • 7Farida Djouad, Vanessa Fritz, Florence Apparailly et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor-a in collagen-induced arthritis [ J ]. Arthritis & Rheumatism, 2005 ; 52 (5) : 1595-1603.
  • 8Karussis D, Kassis I, Basan G S et al. Immunomodulation and neumprotection with mesenchymal bone marrow stem cells (MSCs) : A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases[J] .J Neurol Sci,2008;265(1-2) : 131-135.
  • 9Romanov Y A,Svintsitskaya V A,Smimov V Net al .Searching for alternative sources of postnatal human mesenchymal stem cells:candidate MSC-like cells from umbilical cord[J]. Stem Cell,2003;21 : 105-110.
  • 10Chang C J, Yen M L, Chen Y C et al. Placenta-derived muhipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-γ[ J ]. Stem Cell ,2006;24( 11 ) :2466-2477.

共引文献30

同被引文献34

  • 1栾希英,刘同慎,曹奇志.人胎盘源间充质干细胞对T细胞周期及其活化的抑制作用研究[J].中国现代医学杂志,2008,18(21):3142-3145. 被引量:10
  • 2王景昌,白海,吴涛,路继红,欧剑峰.人骨髓间充质干细胞对异体T淋巴细胞增殖的影响及机制研究[J].实用医学杂志,2006,22(5):494-496. 被引量:2
  • 3Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses [J]. Blood, 2005, 105(4): 1815-1822.
  • 4Itakura S, Asari S, Rawson J, et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHO in the rat [J]. Am J Transplant, 2007 ,7 (2) : 336- 346.
  • 5Tse WT, Pendleton JO, Beyer WM, et al. Suppression of allogeneic T-cell proliferation hy human marrow stromal cells: implications in transplantation [J]. Transplantation, 2003,75 (3) :389-397.
  • 6Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: from culture to clinic [J]. Exp Hematol, 2008, 36 (6): 733-741.
  • 7Spaggiari GM, Capobianco A, Abdelrazik H, et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3- dioxygenase and prostaglandin E2 [J]. Blood, 2008, 111 (3) : 1327-1333.
  • 8Hof-Nahor I, Leshansky L, Shivtiel S, et al. Human mesenchymal stem cells shift C08 + T cells towards a suppressive phenotype by inducing tolerogenicmonocytes [J]. J Cell Sic, 2012,125( 19) :4640-4650.
  • 9Menge T, Gerber M, Wataha K, et al. Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/J3- catenin signaling pathway [J]. Stem Cells Dev, 2013, 22 ( 1) : 148-157.
  • 10Zafranskaya M, Nizheharodava D, Yurkevich M, et al. PGE2 contributes to in vitro MSC-mediated inhibition of non-specific and antigen-specific T cell proliferation in MS patients [J]. Scand J Immunol, 2013,78 (5) : 455-462.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部